New cell injection could ease thumb arthritis pain

NCT ID NCT06459063

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This early study tests an injection called Allocetra for osteoarthritis at the base of the thumb. The trial includes 46 adults aged 40 and older whose pain hasn't improved with standard treatments. Researchers are checking if the injection is safe and whether it can reduce pain and improve hand function compared to a placebo.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Allocetra (a cell therapy injection)
What this could lead to
If it works, this could point toward a new injection to ease pain and improve hand function in people with thumb osteoarthritis.
What could go wrong
This is a very early, small study (46 people) focused mainly on safety. It's too soon to know if Allocetra actually helps, and it may not work better than a placebo.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OSTEOARTHRITIS THUMB are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Kaplan Medical Center

    Rehovot, Israel

More trials for these conditions

Other studies related to the condition(s) this trial covers.